WallStreetZenWallStreetZen

NYSE: RDY
Dr Reddys Laboratories Ltd Stock Forecast, Predictions & Price Target

Analyst price target for RDY

Based on 1 analyst offering 12 month price targets for Dr Reddys Laboratories Ltd.
Min Forecast
$67.00+26.51%
Avg Forecast
$67.00+26.51%
Max Forecast
$67.00+26.51%

Should I buy or sell RDY stock?

Based on 1 analyst offering ratings for Dr Reddys Laboratories Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RDY stock forecasts and price targets.

RDY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 17%
17
Strong BuyMaintains$67.00+26.20%2022-10-31

1 of 1

Forecast return on equity

Is RDY forecast to generate an efficient return?
Company
22.33%
Industry
26.41%
Market
57.51%
RDY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RDY forecast to generate an efficient return on assets?
Company
14.53%
Industry
13.46%
RDY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RDY earnings per share forecast

What is RDY's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.65+42.09%
Avg 2 year Forecast
$3.03+62.47%
Avg 3 year Forecast
$3.26+74.8%
RDY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

RDY revenue forecast

What is RDY's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.0B+5.58%
Avg 2 year Forecast
$3.3B+16.46%
Avg 3 year Forecast
$3.5B+24.9%
RDY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RDY earnings growth forecast

How is RDY forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
28.32%
Industry
17.43%
Market
27.21%
RDY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RDY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RDY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RDY revenue growth forecast

How is RDY forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
9.08%
Industry
1.96%
Market
11.03%
RDY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RDY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RDY vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
RDY$53.09$67.00+26.20%Strong Buy
CTLT$56.05$81.71+45.79%Buy
ELAN$13.87$18.00+29.78%Hold
TEVA$10.76$10.63-1.25%Hold
PRGO$37.20$47.33+27.24%Strong Buy

Dr Reddys Laboratories Stock Forecast FAQ

Is Dr Reddys Laboratories Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: RDY) stock is to Strong Buy RDY stock.

Out of 1 analyst, 1 (100%) are recommending RDY as a Strong Buy, 0 (0%) are recommending RDY as a Buy, 0 (0%) are recommending RDY as a Hold, 0 (0%) are recommending RDY as a Sell, and 0 (0%) are recommending RDY as a Strong Sell.

If you're new to stock investing, here's how to buy Dr Reddys Laboratories stock.

What is RDY's earnings growth forecast for 2023-2025?

(NYSE: RDY) Dr Reddys Laboratories's forecast annual earnings growth rate of 28.32% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 17.43%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 27.21%.

Dr Reddys Laboratories's earnings in 2023 is $300,612,244.On average, 3 Wall Street analysts forecast RDY's earnings for 2023 to be $441,028,500, with the lowest RDY earnings forecast at $429,378,690, and the highest RDY earnings forecast at $447,685,534. On average, 3 Wall Street analysts forecast RDY's earnings for 2024 to be $504,270,322, with the lowest RDY earnings forecast at $474,313,670, and the highest RDY earnings forecast at $537,555,492.

In 2025, RDY is forecast to generate $542,548,268 in earnings, with the lowest earnings forecast at $539,219,751 and the highest earnings forecast at $545,876,785.

What is RDY's revenue growth forecast for 2023-2025?

(NYSE: RDY) Dr Reddys Laboratories's forecast annual revenue growth rate of 9.08% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 1.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.03%.

Dr Reddys Laboratories's revenue in 2023 is $2,734,579,081.On average, 2 Wall Street analysts forecast RDY's revenue for 2023 to be $494,370,314,416, with the lowest RDY revenue forecast at $492,756,982,236, and the highest RDY revenue forecast at $495,983,813,022. On average, 2 Wall Street analysts forecast RDY's revenue for 2024 to be $545,314,265,350, with the lowest RDY revenue forecast at $538,871,920,736, and the highest RDY revenue forecast at $551,756,776,391.

In 2025, RDY is forecast to generate $584,843,899,431 in revenue, with the lowest revenue forecast at $581,909,645,287 and the highest revenue forecast at $587,778,320,000.

What is RDY's forecast return on assets (ROA) for 2023-2025?

(NYSE: RDY) forecast ROA is 14.53%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.46%.

What is RDY's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RDY price target, the average RDY price target is $67.00, with the highest RDY stock price forecast at $67.00 and the lowest RDY stock price forecast at $67.00.

The Wall Street analyst predicted that Dr Reddys Laboratories's share price could reach $67.00 by Oct 31, 2023. The average Dr Reddys Laboratories stock price prediction forecasts a potential upside of 26.2% from the current RDY share price of $53.09.

What is RDY's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: RDY) Dr Reddys Laboratories's current Earnings Per Share (EPS) is $1.81. On average, analysts forecast that RDY's EPS will be $2.65 for 2023, with the lowest EPS forecast at $2.58, and the highest EPS forecast at $2.69. On average, analysts forecast that RDY's EPS will be $3.03 for 2024, with the lowest EPS forecast at $2.85, and the highest EPS forecast at $3.23. In 2025, RDY's EPS is forecast to hit $3.26 (min: $3.24, max: $3.28).

What is RDY's forecast return on equity (ROE) for 2023-2025?

(NYSE: RDY) forecast ROE is 22.33%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.